Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6). | Target Oncol | 2023 | 37488307 | PubTator, text mining | PubMed |
| CTCs Detection and Whole-exome Sequencing Might Be Used to Differentiate Benign and Malignant Pulmonary Nodules. | Zhongguo Fei Ai Za Zhi | 2023 | 37488082 | PubTator, text mining | PubMed |
| Deciphering Brain Metastasis Stem Cell Properties From Colorectal Cancer Highlights Specific Stemness Signature and Shared Molecular Features. | Cell Mol Gastroenterol Hepatol | 2023 | 37482243 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma. | BMC Urol | 2023 | 37479989 | PubTator, text mining | PubMed |
| Super Enhancer Driven Hyaluronan Synthase 3 Promotes Malignant Progression of Nasopharyngeal Carcinoma. | J Cancer | 2023 | 37476195 | PubTator, text mining | PubMed |
| Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. | Genome Med | 2023 | 37475004 | PubTator, text mining | PubMed |
Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy. | Front Oncol | 2023 | 37469401 | PubTator, text mining | PubMed |
| Research progress of biomarkers in the prediction of anti-PD-1/PD-L1 immunotherapeutic efficiency in lung cancer. | Front Immunol | 2023 | 37465684 | PubTator, text mining | PubMed |
| Treatment approaches for urachal cancer: Use of immunotherapy and targeted therapies. | Rare Tumors | 2023 | 37465663 | PubTator, text mining | PubMed |
| Mutational profiling of Chinese patients with thyroid cancer. | Front Endocrinol (Lausanne) | 2023 | 37465126 | PubTator, text mining | PubMed |
| Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS. | NPJ Genom Med | 2023 | 37463940 | PubTator, text mining | PubMed |
| Molecular profiling of gastric neuroendocrine carcinomas. | Eur J Surg Oncol | 2023 | 37463826 | PubTator, text mining | PubMed |
| Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors. | J Am Soc Mass Spectrom | 2023 | 37463068 | PubTator, text mining | PubMed |
| Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients. | Eur J Med Res | 2023 | 37461056 | PubTator, text mining | PubMed |
| Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor. | Nat Commun | 2023 | 37460463 | PubTator, text mining | PubMed |
| Chromosome conformation capture technologies as tools to detect structural variations and their repercussion in chromatin 3D configuration. | Front Cell Dev Biol | 2023 | 37457299 | PubTator, text mining | PubMed |
| FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer. | Front Cell Dev Biol | 2023 | 37457292 | PubTator, text mining | PubMed |
| Genetic mutations in smoking-associated prostate cancer. | Prostate | 2023 | 37455402 | PubTator, text mining | PubMed |
| The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. | Hum Genomics | 2023 | 37454130 | PubTator, text mining | PubMed |
| The Clinical Significance of Genetic Variation in Ovarian Cancer. | Int J Mol Sci | 2023 | 37446001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=27